Precision Medicine in Central Nervous System Drug Development Precision medicine, which has been pioneered by the field of oncology, aims to target the right treatments to the right patients at the right time. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Microbiome: Hope or Hype? This whitepaper discusses how will microbiome impact human therapeutics, who's driving it, and why. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
National Institute of Health Small Business Programs This guide reviews the description of the programs and goals, tips on applying, and resources available to researchers and small/startup businesses interested in translating their technologies into commercial products. BioPharma Life Sciences Other Topics Whitepapers
The Nuts & Bolts of Selecting a Contract Research Organization This whitepaper discusses how to determine internal champions/selection committees, strategic sourcing/Procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
M&A Integration‚ Maximizing the Return on Technology and Talent This whitepaper delves into the web panel discussion – "M&A Integration: Maximizing Return on Technology & Talent" addressing key areas of focus that help drive business decisions related to technology and talent. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers
Gene & Cell Therapies This whitepaper explores the state-of-the-art, the potential and challenges ahead for advanced therapies. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Maximizing M&A Value, Minimizing Surprises This white paper discusses key M&A trends and common reasons why realized value is often lower than expected value during the deal process. Best Practices & Trends Finance Mergers & Acquisitions Valuation Whitepapers
Best Practices for Responding to Inbound M&A Solicitations This white paper focuses on the various types of buyers and their motivations, how to determine if entertaining an offer is the right decision for your business, how to determine the seller’s goals and roles post sale, what not to do when responding to offers, and how to match your desired outcome with the appropriate type of buyer. Best Practices & Trends Finance Mergers & Acquisitions Whitepapers
Non-Immuno-Oncology and Immuno-Oncology Partnering and Development: What’s the Role of Non-IO in an IO World? This whitepaper discusses the role of non-immuno-oncology therapies for cancer in a world where immuno-oncology is playing a greater role. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
Understanding Reps & Warranties Insurance in M&A This whitepaper dives into how representations and warranties insurance can play an integral part of negotiating transactions, winning bids, and finding a means of closing deals in today’s challenging M&A environment. Finance Mergers & Acquisitions Other Topics Whitepapers
The Seven Deadly Sins of M&A In this whitepaper, David Stastny summarizes the "seven deadly sins" that cause reduced purchase prices or failed M&A exits. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers
Building a Better Partnering Presentation Whether seeking a partnership with another company to obtain funds, or looking to advance a drug candidate or technology, organizations need to present opportunities as attractively as possible to persuade potential partners. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers